BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15126775)

  • 1. Tumor seeding in urological laparoscopy: an international survey.
    Micali S; Celia A; Bove P; De Stefani S; Sighinolfi MC; Kavoussi LR; Bianchi G
    J Urol; 2004 Jun; 171(6 Pt 1):2151-4. PubMed ID: 15126775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of local and port site recurrence of urologic cancer after laparoscopic surgery.
    Tanaka K; Hara I; Takenaka A; Kawabata G; Fujisawa M
    Urology; 2008 Apr; 71(4):728-34. PubMed ID: 18279936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological safety of laparoscopic surgery for urological malignancy: experience with more than 1,000 operations.
    Rassweiler J; Tsivian A; Kumar AV; Lymberakis C; Schulze M; Seeman O; Frede T
    J Urol; 2003 Jun; 169(6):2072-5. PubMed ID: 12771722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Port site metastasis and tumor seeding in oncologic laparoscopic urology.
    Castillo OA; Vitagliano G
    Urology; 2008 Mar; 71(3):372-8. PubMed ID: 18342166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic port-site metastasis in urologic surgery.
    Eng MK; Katz MH; Bernstein AJ; Shikanov S; Shalhav AL; Zorn KC
    J Endourol; 2008 Aug; 22(8):1581-5. PubMed ID: 18620507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor seeding following laparoscopy: international survey.
    Paolucci V; Schaeff B; Schneider M; Gutt C
    World J Surg; 1999 Oct; 23(10):989-95; discussion 996-7. PubMed ID: 10512937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multi-institution, minimally invasive urological oncology fellowship: a critical assessment of the clinical training and academic benefits.
    Brown JA; Lewis RW
    J Urol; 2006 Dec; 176(6 Pt 1):2619-23; discussion 2623. PubMed ID: 17085174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Port site recurrences after laparoscopic surgery. A review.
    Schaeff B; Paolucci V; Thomopoulos J
    Dig Surg; 1998; 15(2):124-34. PubMed ID: 9845574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retroperitoneal laparoscopic surgery and carcinogenic risk].
    Cicco A; Salomon L; Saint F; Hoznek A; Chopin D; Abbou CC
    Prog Urol; 2001 Feb; 11(1):8-15. PubMed ID: 11296653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinological risks and retroperitoneal laparoscopy.
    Cicco A; Salomon L; Hoznek H; Alame W; Saint F; Bralet MP; Antiphon P; Chopin DK; Abbou CC
    Eur Urol; 2000 Nov; 38(5):606-12. PubMed ID: 11096244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic staging of bladder tumor: concerns about port site metastases.
    Elbahnasy AM; Hoenig DM; Shalhav A; McDougall EM; Clayman RV
    J Endourol; 1998 Feb; 12(1):55-9. PubMed ID: 9531153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What are the oncological risks of minimal access surgery for the treatment of urinary tract cancer?
    Stewart GD; Tolley DA
    Eur Urol; 2004 Oct; 46(4):415-20. PubMed ID: 15363552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Port site metastasis. An unresolved problem in laparoscopic surgery. A review.
    Martinez J; Targarona EM; Balagué C; Pera M; Trias M
    Int Surg; 1995; 80(4):315-21. PubMed ID: 8740676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective clinical trial of the feasibility and safety of modified retroperitoneal lymph node dissection at time of nephroureterectomy for upper tract urothelial carcinoma.
    Rao SR; Correa JJ; Sexton WJ; Pow-Sang JM; Dickinson SI; Lin HY; Spiess PE
    BJU Int; 2012 Dec; 110(11 Pt B):E475-80. PubMed ID: 22564727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic port site metastases: incidence, risk factors, and potential preventive measures.
    Lee BR; Tan BJ; Smith AD
    Urology; 2005 Apr; 65(4):639-44. PubMed ID: 15833498
    [No Abstract]   [Full Text] [Related]  

  • 16. Laparoscopic Retroperitoneal Lymph Node Dissection for Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Safety and Efficacy Analyses at a High Volume Center.
    Nicolai N; Tarabelloni N; Gasperoni F; Catanzaro M; Stagni S; Torelli T; Tesone A; Bettin L; Necchi A; Giannatempo P; Raggi D; Colecchia M; Piva L; Salvioni R; Paganoni AM; Pizzocaro G; Biasoni D
    J Urol; 2018 Mar; 199(3):741-747. PubMed ID: 28964782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological risk of laparoscopic surgery in urothelial carcinomas.
    RouprĂȘt M; Smyth G; Irani J; Guy L; Davin JL; Saint F; Pfister C; Wallerand H; Rozet F
    World J Urol; 2009 Feb; 27(1):81-8. PubMed ID: 19020880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: the danger of postchemotherapy laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma.
    Spermon JR; Witjes JA
    J Endourol; 2008 May; 22(5):1013-6. PubMed ID: 18429687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urological cancer].
    Kato M; Higashihara E
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1255-9. PubMed ID: 16184920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic nephroureterectomy: long-term outcomes.
    Eng MK; Shalhav AL
    Curr Opin Urol; 2008 Mar; 18(2):157-62. PubMed ID: 18303536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.